In the midst of the pandemic, AstraZeneca marketers were looking for a way to reach oncology healthcare professionals and promote the groundbreaking approval of a new indication for TAGRISSO, a targeted therapy for EGFR+ Non-Small Cell Lung Cancer. This in-demand audience is bombarded with new reports daily, so it was important to break through the noise and connect with them in a valuable way.
The TAGRISSO marketing team looked for places to reach their target in a professional yet personal environment. They selected LinkedIn to run a pilot Sponsored Messaging campaign, and the results exceeded expectations, providing the highest click-through rate (CTR) the product has seen on any social media platform.
Contact us if you have any suggestions on resources you would like to see more of, or if you have something you think would benefit our members.
Get in TouchSign up to receive updates on events, training and more from the MA.